Nuvectis Pharma
NVCT
NVCT
37 hedge funds and large institutions have $20M invested in Nuvectis Pharma in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+25
Holders Change %
+208.33%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
8
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$5.02M |
| 2 |
State Street
Boston,
Massachusetts
|
$1.68M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
$1.8M |
| 4 |
JMFC
J.M. Forbes & Co
Boston,
Massachusetts
|
$1.07M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$4.25M |
